Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Vericel Corporation
ATQPCurrent price
41.8 EUR
0 EUR (0.00%)
Last closed
42.8 EUR
Company
–
ISIN
US92346J1088
Sector
Healthcare
Industry
Biotechnology
Exchange
Frankfurt Exchange
Capitalization
2 279 569 953 EUR
Yield for 12 month
+34.84 %
1Y
3Y
5Y
10Y
15Y
ATQP
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns; and NexoBrid, a biological orphan product for eschar removal in adults with deep partial-thickness and/or full-thickness thermal burns. The company was formerly known as Aastrom Biosciences, Inc. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts. Address: 64 Sidney Street, Cambridge, MA, United States, 02139
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
58.65 EURP/E ratio
4620Dividend Yield
–Current Year
+178 100 177 EUR
Last Year
+148 207 921 EUR
Current Quarter
+47 485 325 EUR
Last Quarter
+46 240 078 EUR
Current Year
+122 248 879 EUR
Last Year
+98 995 840 EUR
Current Quarter
+33 003 122 EUR
Last Quarter
+31 878 702 EUR
Key Figures ATQP
1 year
3 years
5 years
10 years
EBITDA
1 179 892 EUR
Operating Margin TTM
PE Ratio
4620
Return On Assets TTM
-0.7 %
PEG Ratio
–
Return On Equity TTM
0.36 %
Wall Street Target Price
58.65 EUR
Revenue TTM
213 956 457 EUR
Book Value
4.96 EUR
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
14.7 %
Dividend Yield
–
Gross Profit TTM
109 499 588 EUR
Earnings per share
0.01 EUR
Diluted Eps TTM
0.01 EUR
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
104.5 %
Profit Margin
0.37 %
Dividend Analytics ATQP
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ATQP
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:20
Payout Ratio
–
Last Split Date
16.10.2013
Dividend Date
–
Stock Valuation ATQP
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
4620
Forward PE
270.2703
Enterprise Value Revenue
11.7728
Price Sales TTM
10.6544
Enterprise Value EBITDA
349.8397
Price Book MRQ
10.3295
Financials ATQP
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ATQP
For 52 weeks
29.12 EUR
48.67 EUR
50 Day MA
43.68 EUR
Shares Short Prior Month
–
200 Day MA
40.77 EUR
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart